Advertisement
Advertise on MSK
Musculoskeletal Report
January 04, 2011
MSK Report Video Podcasts

Meeting Highlights

ISEMIR 2009: Video coverage of the Meeting
Miami, March 27, 2009
RWCS 2009: Video coverage of the Symposium
Maui, January 14-17, 2009
ACR 2008: News from the Annual Scientific Meeting
San Francisco, October 24-29, 2008
EULAR 2008: Coverage of the Congress
Paris, June 11-14, 2008
ISEMIR 2008: Video coverage of the Meeting
Chicago, April 10, 2008
AAOS 2008: News from the Annual Meeting
San Francisco, March 5-9, 2008

Affiliations

Arthritis Research
Lupus Research Institute - Letting Science Lead the Way to a Cure
RSS Feeds
advertisement
Ad Women's Healthcare Forum

EULAR 2009 News


EULAR Reports Link High Glutamate to Fibromyalgia Pain
July 9, 2009
Two studies on glutamate in brains of fibromyalgia patients show abnormal levels of the neurotransmitter in areas related to pain perception and emotional processing...


Gum Disease Prominent in RA, but TNF-Blockade Can Help
June 26, 2009
Three new studies shed light on the connection between rheumatoid arthritis (RA) and periodontitis, and new data help define a role for TNF-blockade in improving periodontal status as well as RA signs and symptoms...


From Inflammation to Bone Formation in SpA
June 25, 2009
Clinical and animal data reported at EULAR suggest that both controlling inflammation and preventing new bone formation may be required to stop ankylosing spondylitis progression...


Pegloticase Shrinks Tophi Even in Resistant Gout
June 25, 2009
Pegloticase significantly reduced tophus size in 40% of treatment-failure gout patients...


IL-Blockade with Canakinumab Effective, Safe in JIA
June 22, 2009
Phase II data show that canakinumab (ACZ885) seems effective and safe in children with systemic juvenile idiopathic arthritis...


EULAR Studies Show New Picture of B-Cell Depletion in RA
June 22, 2009
A group of studies reported at EULAR show that B-cell depletion is a relatively safe and effective treatment option for patients with rheumatoid arthritis (RA)...


EULAR Report Shows Tocilizumab Protects Joints in RA
June 17, 2009
Actemra® maintained structure and function in a wide range of RA patients in the LITHE study, with response durations of 2 years in interim analyses...

Result Page:  (   [ 1 ]   2  )   Next »